首页 | 本学科首页   官方微博 | 高级检索  
     

改良电抽搐治疗对抑郁发作患者甲状腺功能和性激素的影响
引用本文:汤晨东,沈小燕,郑瑶,査显友,李亚玲,李国荣,唐建良. 改良电抽搐治疗对抑郁发作患者甲状腺功能和性激素的影响[J]. 中华全科医学, 2016, 14(7): 1129-1131. DOI: 10.16766/j.cnki.issn.1674-4152.2016.07.022
作者姓名:汤晨东  沈小燕  郑瑶  査显友  李亚玲  李国荣  唐建良
作者单位:嘉兴市康慈医院精神科, 浙江 嘉兴 314500
基金项目:浙江省桐乡市科技计划项目(201302045)
摘    要:目的 探讨抑郁发作患者接受改良电抽搐治疗(modified electroconvulsive therapy,MECT)后甲状腺功能和性激素的变化。 方法 选择符合ICD-10诊断标准的抑郁发作患者57例,采用化学发光免疫法分别检测MECT治疗后30 min和疗程结束后的血清游离三碘甲状腺原氨酸(FT3)、游离甲状腺功能(FT4)、促甲状腺功能(TSH)、三碘甲状腺原氨酸(T3)、甲状腺功能(T4)、睾酮(T)、雌二醇(E2)及血清泌乳素(PRL)。采用汉密尔顿抑郁量表17项版(Hamilton Depression Rating Scale,HAMD)对治疗前后的抑郁发作患者进行症状严重程度评定。分析甲状腺功能及性激素与HAMD评分的相关性。 结果 MECT治疗后30 min,甲状腺功能无明显变化(P>0.05),E2水平显著下降(P<0.01),PRL水平显著升高(P<0.01)。MECT疗程结束后,T3、FT3和E2水平显著增高(P<0.01)。MECT治疗前后T3水平与HAMD中阻滞因子负相关(r=-0.480,r=-0.471,P<0.01),T水平与HAMD中阻滞因子负相关(r=-0.412,r=-0.385,P<0.01),其他甲状腺功能和性激素与HAMD评分各因子分无相关。 结论 经MECT治疗的抑郁发作患者可以监测其甲状腺功能水平及性激素水平,以便于临床医生观察疗效和调整治疗方案。 

关 键 词:MECT   抑郁发作   甲状腺功能   性激素
收稿时间:2015-03-10

Effect of modified electroconvulsive therapy on thyroxine and sex-hormone of patients experiencing an episode of depression
Affiliation:Department of Psychiatry, Kangci Hospital of Jiaxing, Jiaxing, Zhejiang 314500, China
Abstract:Objective To explore the effect of modified electroconvulsive therapy(MECT) on thyroxine and sex-hormone of the of patients experiencing an episode of depression. Methods Fifty-seven patients meeting the criteria of ICD-10 for depression episode were enrolled into the study.The levels of serum free triiodothyronine(FT3),free thyroxine(FT4),thyroid stimulating hormone(TSH),triiodothyronine(T3),thyroxine(T4),testosterone(T),estradiol(E2) and prolactin(PRL) were tested at 30-minutes after the treatment and the end of treatment.Hamilton Depression Rating Scale(HAMD) was performed before and after the treatment to assessseverity of symptom.The correlations among thyroxine,sex-hormone and scores of HAMD were analyzed. Results Thyroxine had no significant changes,E2 was significantly decreased 30-minutes after the treatment(P<0.01),while PRL was significantly increased after that(P<0.01).T3,FT3 and E2were significantly increased at the end of the treatment(P<0.01).There was significant negative correlation between level of T3 and scores of retardation factor before and after the treatment(r=-0.480,r=-0.471,P<0.01).There was significant negative correlation between level of T and scores of retardation factor before and after the treatment(r=-0.412,r=-0.385,P<0.01) while no correlation among other thyroxine,Sex-hormone and scores of HAMD. Conclusion The clinical doctors can evaluate the efficacy and adjust treatment plan based on the levels of thyroxine and sex-hormone in depressive episodes patients receiving MECT. 
Keywords:
点击此处可从《中华全科医学》浏览原始摘要信息
点击此处可从《中华全科医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号